rs78599682
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_052845.4(MMAB):c.584+24A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.098 in 1,118,204 control chromosomes in the GnomAD database, including 4,169 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.078 ( 361 hom., cov: 26)
Exomes 𝑓: 0.10 ( 3808 hom. )
Consequence
MMAB
NM_052845.4 intron
NM_052845.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.300
Publications
4 publications found
Genes affected
MMAB (HGNC:19331): (metabolism of cobalamin associated B) This gene encodes a protein that catalyzes the final step in the conversion of vitamin B(12) into adenosylcobalamin (AdoCbl), a vitamin B12-containing coenzyme for methylmalonyl-CoA mutase. Mutations in the gene are the cause of vitamin B12-dependent methylmalonic aciduria linked to the cblB complementation group. Alternatively spliced transcript variants have been found. [provided by RefSeq, Apr 2011]
MMAB Gene-Disease associations (from GenCC):
- methylmalonic aciduria, cblB typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-109561016-T-C is Benign according to our data. Variant chr12-109561016-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0784 AC: 10028AN: 127884Hom.: 361 Cov.: 26 show subpopulations
GnomAD3 genomes
AF:
AC:
10028
AN:
127884
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0693 AC: 16796AN: 242440 AF XY: 0.0730 show subpopulations
GnomAD2 exomes
AF:
AC:
16796
AN:
242440
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.101 AC: 99574AN: 990240Hom.: 3808 Cov.: 30 AF XY: 0.102 AC XY: 51225AN XY: 503040 show subpopulations
GnomAD4 exome
AF:
AC:
99574
AN:
990240
Hom.:
Cov.:
30
AF XY:
AC XY:
51225
AN XY:
503040
show subpopulations
African (AFR)
AF:
AC:
2337
AN:
23132
American (AMR)
AF:
AC:
2224
AN:
39014
Ashkenazi Jewish (ASJ)
AF:
AC:
2180
AN:
18176
East Asian (EAS)
AF:
AC:
883
AN:
21374
South Asian (SAS)
AF:
AC:
9779
AN:
79326
European-Finnish (FIN)
AF:
AC:
2838
AN:
33450
Middle Eastern (MID)
AF:
AC:
563
AN:
4354
European-Non Finnish (NFE)
AF:
AC:
74532
AN:
732068
Other (OTH)
AF:
AC:
4238
AN:
39346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4220
8439
12659
16878
21098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2760
5520
8280
11040
13800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0784 AC: 10033AN: 127964Hom.: 361 Cov.: 26 AF XY: 0.0810 AC XY: 4939AN XY: 60962 show subpopulations
GnomAD4 genome
AF:
AC:
10033
AN:
127964
Hom.:
Cov.:
26
AF XY:
AC XY:
4939
AN XY:
60962
show subpopulations
African (AFR)
AF:
AC:
2762
AN:
33832
American (AMR)
AF:
AC:
940
AN:
11686
Ashkenazi Jewish (ASJ)
AF:
AC:
219
AN:
3252
East Asian (EAS)
AF:
AC:
140
AN:
3868
South Asian (SAS)
AF:
AC:
487
AN:
3680
European-Finnish (FIN)
AF:
AC:
647
AN:
6982
Middle Eastern (MID)
AF:
AC:
31
AN:
250
European-Non Finnish (NFE)
AF:
AC:
4606
AN:
61820
Other (OTH)
AF:
AC:
158
AN:
1752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
457
914
1370
1827
2284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
180
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Methylmalonic aciduria, cblB type Benign:1
Jul 01, 2021
Pars Genome Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.